glp 1 hair loss treatment after starting a GLP-1 medication left this patient feeling discouraged, but these early results show what's possible with the right support. This before and after reflects improvement after the first Leaves hair softer Home | GLP Fix

Saxenda (active ingredient: liraglutide) subcutaneous injection Initial FDA Approval: 2014 (liraglutide approved in 2010) Side Effect Update Date: May 28, 2025 Medication Description: For chronic weight management Updated Side Effects/Safety Information: A new warning section on Severe Gastrointestinal Adverse Reactions. An additional warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting

Updated May 5, 2026

Cardiovascular events with finerenone in kidney disease and type 2 diabetes

Garg, A

At Elite Primary Care Group, we understand that every patient is unique

Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made